Breast Cancer Symposium 2012

Be sure to attend these hot topic sessions

Medical Oncology Management including Role of mTOR Inhibitors in Metastatic Disease and Role of Chemotherapy for Small TN and HER2+
Diagnosis of Early Stage Breast Cancer and Management of Sentinel Nodes including an MRI debate and panel discussion on Reconciling the Z0011 Approach
Debates in Systemic Therapy including Anthracyclines and Bisphosphonates (part of GSX)
A pro/con argument on the Role of Local Radiation Therapy in DCIS
+ show speakers and program
Exhibits Open

7:00 AM —
7:45 AM

Continental Breakfast Provided

7:45 AM —
9:00 AM

Welcome & General Session I: Controversial Topics In Medical Oncology Management

Chair: Lori Goldstein, MD – Fox Chase Cancer Center

Role of mTOR Inhibitors in Metastatic Disease
William John Gradishar, MD – Northwestern University
Role of Chemotherapy for Small TN and HER2+ Cancers
Robert Carlson, MD – Stanford Comprehensive Cancer Center
9:00 AM —
9:30 AM

Break

9:30 AM — 11:00 AM

General Session II: Risk Assessment, Prevention, Detection, And Screening

Chair: Banu Arun, MD – M. D. Anderson Cancer Center

What is High Risk, What is the Definition of Genetic Testing and What To Do With the Results
Claudine Isaacs, MD – Georgeotwn University
Imaging Techniques: What Works, What Doesn’t
David A. Mankoff, MD, PhD - University of Washington
The Value of Risk-Reducing Surgery for Premalignant Lesions, DCIS, ADH
Todd M. Tuttle, MD, MS – University of Minnesota
Medical Management/Prevention of Premalignant Lesions DCIS, LCIS, ADH
Victor Vogel, MD, MHS – Geisinger Health System


11:00 AM — 1:00 PM

General Poster Session A

(with complimentary boxed lunch)


11:10 AM — 11:40 AM

Poster Walks

(four groups)

Seema Khan, MD – Northwestern University
Meena S. Moran, MD - Yale University School of Medicine
Lori Pierce, MD – University of Michigan
Shawna Willey, MD – Georgetown University


11:45 AM — 12:45 PM

Tumor Board

Panelists:
Lori J. Pierce, MD – University of Michigan
Shawna Willey, MD – Georgetown University
Daniel Hayes, MD – University of Michigan
Anna Maria Storniolo, MD – IU Simon Cancer Center
Kathryn Evers, MD - Fox Chase Cancer Center


1:00 PM —
2:15 PM

General Session III: Controversies in Diagnosis of Early Stage Breast Cancer and Management of Sentinel Nodes

Chairs: Jennifer Bellon, MD – Dana-Farber Cancer Institute; Richard Bleicher, MD – Fox Chase Cancer Center

MRI Debate
Moderator: Richard Bleicher, MD – Fox Chase Cancer Center
Pro: Constance D. Lehman, MD, PhD, FACR – Seattle Cancer Care Alliance
Con: Kathryn Evers, MD – Fox Chase Cancer Center
Panel Discussion: Reconciling the Z0011 Approach to Nodal Management of Sentinel Node Positive Disease with MA.20
Case Presentations: Jennifer Bellon, MD – Dana-Farber Cancer Institute
Surgeon: Monica Morrow – MD – Memorial Sloan-Kettering Cancer Center
Surgeon: Michael S. Sabel, MD – University of Michigan
Radiation Oncologist: Reshma Jagsi, MD – University of Michigan
Radiation Oncologist: Alice Ho, MD - Memorial Sloan-Kettering Cancer Center
2:15 PM —
2:45 PM

Break

2:45 PM —
4:00 PM

General Session IV: Controversies In Local/Regional Treatment

Chairs: Lori Pierce, MD – University of Michigan; Robert Kuske, MD – Arizona Breast Cancer Specialists

Intraoperative Radiation Therapy: Analysis of a Randomized Trial
Jayant Vaidya, PhD – University College London
Intraoperative Radiation Therapy: A Practical Perspective
Julia White, MD - The Stefanie Spielman Comprehensive Breast Center
Debate on Role of Local Radiation Therapy in DCIS
Moderator: Robert Kuske, MD – Arizona Breast Cancer Specialists
Pro: Thomas B. Julian, MD – Drexel University College of Medicine
Con: Abram Recht, MD - Beth Israel Deaconess Medical Center
4:00 PM —
4:30 PM

Break
4:30 PM —
5:30 PM

Poster Discussion: Risk Assessment, Prevention, Detection, And Screening


5:30 PM —
7:00 PM

General Poster Session A (Continued)
(with complimentary wine and cheese reception)



7:00 AM —
7:00 PM

Exhibits Open

7:00 AM —
8:00 AM

Continental Breakfast Provided

7:00 AM —
8:00 AM

Meet The Professor Sessions

(Three concurrent sessions)

Management of the Clinically Negative Axilla
Monica Morrow, MD – Memorial Sloan-Kettering Cancer Center
Reassessing Local Treatment in the Context of Increasingly Effective Systemic Therapy
Jay R. Harris, MD – Dana-Farber Cancer Institute
Marker-driven Personalized Therapy of Breast Cancer
Gabriel N. Hortobagyi, MD – M. D. Anderson Cancer Center
8:00 AM —
9:15 AM

Welcome and General Session V: Genomics for the Clinician

Chair: Mark D. Pegram, MD - Stanford University

New Horizons in Breast Cancer ‘Omics
Matthew J. Ellis, MD – Washington University
Future Directions in Genomics for Metastatic Disease
Charles E. Geyer, Jr., MD – CTNeT
Role of Genomic Testing in Node Positive Patients
Anna Maria Gonzalez, MD – M. D. Anderson
9:15 AM —
9:45 AM

Break

9:45 AM — 10:30 AM

ASCO Gianni Bonnadonna Breast Cancer Award and Lecture

2012 Awardee is Monica Morrow, MD - Memorial Sloan-Kettering Cancer Center


10:30 AM — 11:15 AM

General Session VI: Healthcare Delivery and Prevention

Chair: Bruce Haffty, MD - The Cancer Institute of New Jersey

Breast Healthcare Delivery in Context: The World Health Organization's Initiative for Non-communicable Diseases
Benjamin O. Anderson, MD - Fred Hutchinson Cancer Research Center

Reducing Breast Cancer Risk: Progress Towards Resolution
Rowan T. Chlebowski, MD, PhD - David Geffen School of Medicine at UCLA
11:15 AM — 1:15 PM

General Poster Session B
(With Complimentary Boxed Lunch Provided)

11:30 AM — 1:00 PM

Poster Walks

(Six groups)

11:30 AM - 12:00 PM
Lori Goldstein, MD – Fox Chase Cancer Center
Sandhya Pruthi, MD – Mayo Clinic

12:00 PM - 12:30 PM
Hope S. Rugo, MD – UCSF Helen Diller Family Comprehensive Cancer Center
William Sikov, MD – Brown University

12:30 PM - 1:00 PM
Kathy S. Albain, MD - Loyola University
Melinda Telli, MD – Stanford University


1:15 PM —
2:45 PM

General Session VII: Survivorship

Chair: Kathy S. Albain, MD - Loyola University; Sandra M. Swain, MD – Washington Cancer Institute

Transition from Active Treatment to “Normal Life” as a Survivor
Denise O'Neill - Holy Cross Hospital
Obesity in Survivorship
Patrick Morris, MD – Memorial Sloan-Kettering Cancer Center
Managing Menopausal Symptoms in Breast Cancer Patients
Patrick Neven, MD – Leuven Cancer Institute
Quality Measures in Survivorship
Ann H. Patridge, MD, PhD – Dana-Farber Cancer Institute
2:45 PM —
3:15 PM

Break

3:15 PM —
4:30 PM

General Session VIII: The Future Of Health Policy

Chair: Richard L. White, Jr., MD – Blumenthal Cancer Center

Reducing Disparities
Claudia R. Baquet, MD, MPH – University of Maryland School of Medicine
What are the Differences Between Using a New Drug and a New Technology
Gary H. Lyman, MD, MPH - Duke University School of Medicine
Rapid Learning Systems
Sandra M. Swain, MD – Washington Cancer Institute
4:30 PM —
4:45 PM

Break

4:45 PM —
5:45 PM

Poster Discussion B: Survivorship And Health Policy


5:45 PM —
7:00 PM

General Poster Session B (Continued)

(with complimentary wine and cheese reception)



6:30 AM —
7:30 AM

Fellows, Residents, And Junior Faculty Networking Breakfast

Chairs: Hope S. Rugo, MD – UCSF Helen Diller Family Comprehensive Cancer Center; Meena S. Moran, MD - Yale University School of Medicine


6:30 AM —
8:00 AM

Continental Breakfast Provided

8:00 AM —
9:30 AM

Welcome And General Session IX: New Directions In Systemic Therapy For Advanced Disease

Chairs: Eric P. Winer, MD – Dana-Farber Cancer Institute; Heather McArthur, MD. MPH – Memorial Sloan-Kettering Cancer Center

An Update on HER2 Positive Breast Cancer
Mark D. Pegram, MD - Stanford University
Hormone Responsive Disease
Francisco J. Esteva, MD, PhD – M. D. Anderson Cancer Center
Treatment strategies for Triple Negative Patients
Lisa A. Carey, MD – Lineberger Comprehensive Cancer Center


Panel Discussion
Moderator: Eric P. Winer, MD - Dana-Farber Cancer Institute
9:30 AM —
9:50 AM

Break And Poster Session C

9:50 AM — 10:40 AM

General Session X: Health Policy: Opportunities And Challenges

Chair: Richard L. White, Jr., MD - Blumenthal Cancer Center

Opportunities Lost
Otis W. Brawley, MD - American Cancer Society

Drug Shortages in Breast Cancer
Thomas Kornberg, PhD - UCSF Helen Diller Family Comprehensive Cancer Center
10:40 AM — 11:00 AM

Break And Poster Session C (Continued)

11:00 AM — 12:30 PM

General Session XI: Debates On Current Controversies In Systemic Therapy

Chairs: Gabriel N. Hortobagyi, MD – M. D. Anderson Cancer Center; Minetta C. Liu, MD – Georgetown University

Use of Anthracyclines in HER2 Positive and HER2 Negative Patients
Moderator: Gabriel N. Hortobagyi, MD – M. D. Anderson Cancer Center
Pro: Clifford A. Hudis, MD – Memorial Sloan-Kettering Cancer Center
Con: Stephen E. Jones, MD - US Oncology Research

Bone Health/Role of Bisphosphonates in Early Stage Breast Cancer
Moderator: Minetta C. Liu, MD - Georgetown University
Pro: Catherine Hall Van Poznak, MD – University of Michigan
Con: Julie R. Gralow, MD – Seattle Cancer Care Alliance

13 Sep - 15 Sep 2012

San Francisco
United States of America
meeting website